Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines.
Vaccine. 2021 Oct 15;39(43):6414-6421. doi: 10.1016/j.vaccine.2021.08.106. Epub 2021 Sep 23.
Vaccine. 2021.
PMID: 34563397
Clinical Trial.
A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults.
Inoue M, Yonemura T, de Solom R, Yamaji M, Aizawa M, Knirsch C, Pride MW, Jansen KU, Gruber W, Webber C.
Inoue M, et al. Among authors: de solom r.
Vaccine. 2019 May 1;37(19):2600-2607. doi: 10.1016/j.vaccine.2019.03.014. Epub 2019 Apr 5.
Vaccine. 2019.
PMID: 30962095
Clinical Trial.
Item in Clipboard
A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants.
Ishihara Y, Fukazawa M, Enomoto S, de Solom R, Yamaji M, Kline M, Aizawa M, Peng Y, Kogawara O, Giardina PC, Tamimi N, Gruber WC, Watson W.
Ishihara Y, et al. Among authors: de solom r.
Int J Infect Dis. 2024 Apr;141:106942. doi: 10.1016/j.ijid.2024.01.009. Epub 2024 Jan 17.
Int J Infect Dis. 2024.
PMID: 38242195
Free article.
Clinical Trial.
Item in Clipboard
A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults ≥ 60 years of age in Japan, South Korea, and Taiwan.
Haranaka M, Young Song J, Huang KC, de Solom R, Yamaji M, McElwee K, Kline M, Aizawa M, Peng Y, Scully I, Kogawara O, Gruber WC, Scott DA, Watson W.
Haranaka M, et al. Among authors: de solom r.
Vaccine. 2024 Feb 15;42(5):1071-1077. doi: 10.1016/j.vaccine.2024.01.004. Epub 2024 Jan 23.
Vaccine. 2024.
PMID: 38267330
Free article.
Clinical Trial.
Item in Clipboard
Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older.
Yonekawa M, Watanabe T, Kogawara O, Yoshii C, Yamaji M, Aizawa M, Erber W, Ito S, Jug B, Koelch D, de Solom R, Lockhart SP.
Yonekawa M, et al. Among authors: de solom r.
Vaccine. 2024 May 10;42(13):3180-3189. doi: 10.1016/j.vaccine.2024.03.071. Epub 2024 Apr 12.
Vaccine. 2024.
PMID: 38614954
Clinical Trial.
Item in Clipboard
Induction interferon and ribavirin for re-treatment of chronic hepatitis C patients unresponsive to interferon alone.
Sievert W, Batey R, Mollison L, Pianko S, McDonald J, Marinos G, Reed W, Warner S, Bowden S, De Solom R, Bhathal P; AusHep Investigators.
Sievert W, et al. Among authors: de solom r.
Aliment Pharmacol Ther. 2003 May 1;17(9):1197-204. doi: 10.1046/j.1365-2036.2003.01544.x.
Aliment Pharmacol Ther. 2003.
PMID: 12752357
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite